LYMPHANGITIC CARCINOMATOSIS
Tracking # 20-814565
$99999.00
There are no ratings for this course
Learn more Educator STATPEARLS PUBLISHING, LLC
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
LYMPHANGITIC CARCINOMATOSIS IS THE INFILTRATION & INFLAMMATION OF LYMPHATIC VESSELS SECONDARY TO THE SPREAD OF MALIGNANCY FROM A PRIMARY SITE. PULMONARY LYMPHANGITIC CARCINOMATOSIS ALMOST ALWAYS REPRESENTS THE CLINICAL FORM OF LYMPHANGITIC CARCINOMATOSIS & DENOTES AN END-STAGE MALIGNANCY WITH POOR PROGNOSIS. THIS ACTIVITY COVERS THE ETIOLOGY, CLINICAL FEATURES, DIAGNOSTIC EVALUATION & MANAGEMENT OF SUSPECTED PULMONARY LYMPHANGITIC CARCINOMATOSIS AND HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN DELIVERING THE BEST OUTCOME IN A GIVEN PATIENT.
Subject areas
This course counts toward the state boards and subject areas below.
Bahamas Medical Council
Specialty Medical Practitioner
1.25h
General Medicine
Louisiana State Board of Medical Examiners - Physicians & Surgeons
Physician & Surgeon
1.25h
Category I CME
Mississippi State Board of Medical Licensure
Medical Doctor
1.25h
AMA Category I
Physician Assistant
1.25h
AMA Category I
State Medical Board of Ohio
Doctor of Medicine
1.25h
AMA Category I